- Home
- WTFC vs MRNA Comparison
WTFC vs MRNA Comparison
Compare WTFC & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTFC
- MRNA
- Stock Information
- Founded
- WTFC 1991
- MRNA 2010
- Country
- WTFC United States
- MRNA United States
- Employees
- WTFC N/A
- MRNA N/A
- Industry
- WTFC Major Banks
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WTFC Finance
- MRNA Health Care
- Exchange
- WTFC Nasdaq
- MRNA Nasdaq
- Market Cap
- WTFC 9.2B
- MRNA 10.9B
- IPO Year
- WTFC N/A
- MRNA 2018
- Fundamental
- Price
- WTFC $138.00
- MRNA $24.01
- Analyst Decision
- WTFC Strong Buy
- MRNA Hold
- Analyst Count
- WTFC 14
- MRNA 19
- Target Price
- WTFC $149.29
- MRNA $43.50
- AVG Volume (30 Days)
- WTFC 374.7K
- MRNA 9.7M
- Earning Date
- WTFC 10-20-2025
- MRNA 11-06-2025
- Dividend Yield
- WTFC 1.43%
- MRNA N/A
- EPS Growth
- WTFC 10.01
- MRNA N/A
- EPS
- WTFC 10.58
- MRNA N/A
- Revenue
- WTFC $2,480,496,000.00
- MRNA $3,078,000,000.00
- Revenue This Year
- WTFC $17.29
- MRNA N/A
- Revenue Next Year
- WTFC $5.95
- MRNA $10.17
- P/E Ratio
- WTFC $13.19
- MRNA N/A
- Revenue Growth
- WTFC 11.93
- MRNA N/A
- 52 Week Low
- WTFC $89.10
- MRNA $23.15
- 52 Week High
- WTFC $142.04
- MRNA $79.96
- Technical
- Relative Strength Index (RSI)
- WTFC 63.83
- MRNA 36.54
- Support Level
- WTFC $134.86
- MRNA $23.33
- Resistance Level
- WTFC $141.69
- MRNA $25.48
- Average True Range (ATR)
- WTFC 2.70
- MRNA 1.06
- MACD
- WTFC 0.61
- MRNA -0.03
- Stochastic Oscillator
- WTFC 75.20
- MRNA 12.88
About WTFC Wintrust Financial Corporation
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.